Abstract
Purpose of Review The purpose of this chapter is to provide a brief review on current anesthesia techniques for transfemoral transcatheter aortic valve implantation (TF-TAVI). Recent Findings TF-TAVI has become a standard treatment option for high risk patients with severe aortic stenosis. Increasing experience with prosthetic durability and equivalent or superior outcomes of transcatheter over surgical aortic valve replacement will boost the caseload of high- and intermediate-risk patients. For TF-TAVI, general anesthesia (GA) had initially been widely preferred over local anesthesia with monitored anesthesia care (LA-MAC), but with large national practice variation. Institutional routines are changing now since evidence from large registries accrues that LA-MAC represents a feasible, safe, and economically sound alternative to GA, if no contraindications apply. Although prospective randomized TAVI anesthesia trials are lacking, observational data show that GA is associated with higher patient risk, longer procedural time, more vasopressor and transfusion requirement, and more resource use and costs, whereas periprocedural mortality is comparable or non-significantly better with LA-MAC. In summary, GA remains a robust solution for specific situations and teams. In many experienced centers, however, LA-MAC has become first choice whenever possible. Whether LA-MAC is an option should be decided upon by the anesthesiologist and the heart team in consultation with the patient, following prospectively defined decision pathways. With increasing caseload and decreasing invasiveness of TAVI technology, anesthesia providers must meet the challenge to reduce resource use and costs without compromising patient safety and satisfaction.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603. doi:10.1161/CIR.0000000000000485.
Danielsen R, Aspelund T, Harris TB, Gudnason V. The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: the AGES-Reykjavík study. Int J Cardiol. 2014;176:916–22. doi:10.1016/j.ijcard.2014.08.053.
Chizner MA, Pearle DL, deLeon AC. The natural history of aortic stenosis in adults. Am Heart J. 1980;99:419–24.
Leon MB, Smith CR, Mack M. et al; PARTNER trial investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.
Sharabiani MTA, Fiorentino F, Angelini GD, Patel NN. Long-term survival after surgical aortic valve replacement among patients over 65 years of age. Open Heart. 2016;3:e000338. doi:10.1136/openhrt-2015-000338.
Authors/Task Force Members, Vahanian A, Alfieri O, et al. Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33:2451–96. doi:10.1093/eurheartj/ehs109.
Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis. 2012;105:146–52. doi:10.1016/j.acvd.2012.01.005.
Saji M, Lim DS. Transcatheter aortic valve replacement in lower surgical risk patients: review of major trials and future perspectives. Curr Cardiol Rep. 2016;18:103. doi:10.1007/s11886-016-0772-3.
Mylotte D, Osnabrugge RLJ, Windecker S, et al. Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization. J Am Coll Cardiol. 2013;62:210–9. doi:10.1016/j.jacc.2013.03.074.
Osnabrugge RLJ, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62:1002–12. doi:10.1016/j.jacc.2013.05.015.
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20. doi:10.1056/NEJMoa1514616.
Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–31. doi:10.1056/NEJMoa1700456.
Mayr NP, Michel J, Bleiziffer S, Tassani P, Martin K. Sedation or general anesthesia for transcatheter aortic valve implantation (TAVI). J Thorac Dis. 2015;7:1518–26. doi:10.3978/j.issn.2072-1439.2015.08.21.
Fröhlich GM, Lansky AJ, Webb J, Roffi M, Toggweiler S, Reinthaler M, et al. Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)—systematic review and meta-analysis. BMC Med. 2014;12:41. doi:10.1186/1741-7015-12-41.
Mayr NP, Hapfelmeier A, Martin K, Kurz A, van der Starre P, Babik B, et al. Comparison of sedation and general anaesthesia for transcatheter aortic valve implantation on cerebral oxygen saturation and neurocognitive outcome. Br J Anaesth. 2016;116(1):90–9. doi:10.1093/bja/aev294.
Goren O, Finkelstein A, Gluch A, Sheinberg N, Dery E, Matot I. Sedation or general anesthesia for patients undergoing transcatheter aortic valve implantation—does it affect outcome? An observational single-center study. J Clin Anesth. 2015;27:385–90. doi:10.1016/j.jclinane.2015.03.025.
Petronio AS, Giannini C, De Carlo M, et al. Anaesthetic management of transcatheter aortic valve implantation: results from the Italian CoreValve registry. EuroIntervention. 2016;12:381–8. doi:10.4244/EIJY15M03_05.
• Toppen W, Johansen D, Sareh S, et al. Improved costs and outcomes with conscious sedation vs general anesthesia in TAVR patients: time to wake up? PLoS One. 2017;12:e0173777. doi:10.1371/journal.pone.0173777. Cost analysis of a single center with retrospective evidence for cost effectiveness of LA-MAC
• Kiramijyan S, Ben-Dor I, Koifman E, et al. Comparison of clinical outcomes with the utilization of monitored anesthesia care vs. general anesthesia in patients undergoing transcatheter aortic valve replacement. Cardiovasc Revasc Med. 2016;17:384–90. doi:10.1016/j.carrev.2016.02.003. Single center experience with retrospective analysis of indications for intraprocedural conversion from LA-MAC to GA
• Brecker SJD, Bleiziffer S, Bosmans J, Gerckens U, Tamburino C, Wenaweser P, et al. ADVANCE study investigators. Impact of anesthesia type on outcomes of transcatheter aortic valve implantation (from the multicenter ADVANCE study). Am J Cardiol. 2016;117:1332–8. doi:10.1016/j.amjcard.2016.01.027. A multicenter, secondary analysis showing that there are large national differences in utilization of LA-MAC vs. GA.
D'Errigo P, Ranucci M, Covello RD, et al. Outcome after general anesthesia versus monitored anesthesia care in transfemoral transcatheter aortic valve replacement. J Cardiothorac Vasc Anesth. 2016;30:1238–43. doi:10.1053/j.jvca.2016.05.034.
Jabbar A, Khurana A, Mohammed A, Das R, Zaman A, Edwards R. Local versus general anesthesia in transcatheter aortic valve replacement. Am J Cardiol. 2016;118:1712–6. doi:10.1016/j.amjcard.2016.08.051.
Roten L, Wenaweser P, Delacrétaz E, et al. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol. 2010;106:1473–80. doi:10.1016/j.amjcard.2010.07.012.
Cribier A, Eltchaninoff H, Bash A, Borenstein N. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis. Circulation Circulation. 2002;106(24):3006–8. doi:10.1161/01.CIR.0000047200.36165.B8.
Cerrato E, Nombela-Franco L, Nazif TM, et al. Evaluation of current practices in transcatheter aortic valve implantation: the WRITTEN (WoRldwIde TAVI ExperieNce) survey. Int J Cardiol. 2017;228:640–7. doi:10.1016/j.ijcard.2016.11.104.
Bufton KA, Augoustides JG, Cobey FC. Anesthesia for transfemoral TAVR in North America and Europe. J Cardiothor Vasc Anesth. 2013;27:46–9. doi:10.1053/j.jvca.2012.08.008.
Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 2012;42:S45–60. doi:10.1093/ejcts/ezs533.
GALA Trial Collaborative Group, Lewis SC, Warlow CP, et al. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet. 2008;372:2132–42. doi:10.1016/S0140-6736(08)61699-2.
Bruder EA, Ball IM, Ridi S, Pickett W, Hohl C. Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients. Cochrane Database Syst Rev. 2015;1:CD010225. doi:10.1002/14651858.CD010225.pub2.
Lamperti M. Adult procedural sedation: an update. Curr Opin Anaesthesiol. 2015;28:662–7. doi:10.1097/ACO.0000000000000244.
Wutzler A, Huemer M, Boldt L-H, Parwani AS, Attanasio P, Tscholl V, et al. Effects of deep sedation on cardiac electrophysiology in patients undergoing radiofrequency ablation of supraventricular tachycardia: impact of propofol and ketamine. Europace. 2013;15:1019–24. doi:10.1093/europace/eut025.
Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017;77:1125–1. doi:10.1093/europace/eut025.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Jan-Oliver Friess declares that he has no conflict of interest.
Kalgini Durrer Ariyakuddy declares that she has no conflict of interest.
Balthasar Eberle has received speaker’s honoraria from Medtronic.
Gabor Erdoes declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Cardiovascular Anesthesia
Rights and permissions
About this article
Cite this article
Friess, JO., Ariyakuddy, K.D., Eberle, B. et al. General Anesthesia or Monitored Anesthesia Care for Transfemoral Transcatheter Aortic Valve Implantation: Current Trends and Future Directions. Curr Anesthesiol Rep 7, 283–290 (2017). https://doi.org/10.1007/s40140-017-0225-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40140-017-0225-6